Armata Pharmaceuticals (ARMP) Assets: 2013-2018
Historic Assets for Armata Pharmaceuticals (ARMP) over the last 5 years, with Sep 2018 value amounting to $10.6 million.
- Armata Pharmaceuticals' Assets fell 22.94% to $10.6 million in Q3 2018 from the same period last year, while for Sep 2018 it was $10.6 million, marking a year-over-year decrease of 22.94%. This contributed to the annual value of $11.1 million for FY2017, which is 38.64% down from last year.
- Per Armata Pharmaceuticals' latest filing, its Assets stood at $10.6 million for Q3 2018, which was down 9.39% from $11.7 million recorded in Q2 2018.
- Armata Pharmaceuticals' Assets' 5-year high stood at $38.6 million during Q1 2015, with a 5-year trough of $10.6 million in Q3 2018.
- Its 3-year average for Assets is $17.5 million, with a median of $14.4 million in 2018.
- As far as peak fluctuations go, Armata Pharmaceuticals' Assets rose by 10.05% in 2015, and later slumped by 49.39% in 2017.
- Over the past 5 years, Armata Pharmaceuticals' Assets (Quarterly) stood at $28.6 million in 2014, then rose by 10.05% to $31.5 million in 2015, then tumbled by 42.36% to $18.2 million in 2016, then tumbled by 38.64% to $11.1 million in 2017, then dropped by 22.94% to $10.6 million in 2018.
- Its last three reported values are $10.6 million in Q3 2018, $11.7 million for Q2 2018, and $14.4 million during Q1 2018.